APP and amnesia: Kim et al. [39], using APP transgenic mice forming Aβ-oligomers (APP E693Q), documented that the group II mGluR antagonist (BCL-632) has strong potential to reverse transgene-associated amnesia, reduced anxiety, and Aβ mono- and oligomers.